Designates Xylazine as a schedule III depressant controlled substance.

SB 300 Designates Xylazine as a schedule III depressant controlled substance

New York 2017-2018 General Assembly

Bill Texts

Introduced 01/04/2017

Weigh In


Sponsors (12)